share_log

奥赛康:关于子公司利厄替尼片上市许可申请获受理的公告

Beijing Aosaikang Pharmaceutical: Announcement regarding the acceptance of the application for the listing permit of the subsidiary's Erlotinib tablets.

SZSI ·  Aug 12, 2024 09:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more